Anti-monocyte chemoattractant protein-1 gene therapy for cardiovascular diseases.

Biochemistry, Genetics and Molecular Biology

• Protein 100%
• Monocyte 100%
• Gene Therapy 50%
• Rat 33%
• Leporidae 33%
• Haplorhini 33%
• Synthesis 16%
• Nested Gene 16%
• Development 16%
• Transfection 16%
• N-Terminus 16%
• Nitric Oxide 16%
• Skeletal Muscle 16%
• Deletion Mutant 16%
• Apolipoprotein E Knockout Mouse 16%

Medicine and Dentistry

• Monocyte Chemotactic Protein 1 100%
• Gene Therapy 50%
• Cardiovascular Disease 50%
• Stent 33%
• Gene 16%
• Development 16%
• Nitric Oxide 16%
• Pathogenesis 16%
• Genetic Transfection 16%
• Neointima 16%
• Injury 16%
• Skeletal Muscle 16%
• Amino Terminal Sequence 16%
• Restenosis 16%
• Deletion Mutant 16%
• Atherosclerosis 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Monocyte Chemotactic Protein 1 100%
• Cardiovascular Disease 50%
• Rat 33%
• Leporidae 33%
• Haplorhini 33%
• Neointima 16%
• Injury 16%
• Pathogenesis 16%
• Atherosclerosis 16%
• Nitric Oxide 16%
• Apolipoprotein E Knockout Mouse 16%
• Restenosis 16%